AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
PDF (2.5 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Erratum

Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs

Yuanhao Yu1,§, Shiyi Zuo2,§, Jiaxuan Song2,§, Lingxiao Li2, Tian Liu2, Jiayu Guo2, Yaqiao Li2, Danping Wang1, Qi Lu2, Helin Wang2, Dun Zhou3, Zhonggui He2, Xiaohong Liu1( ), Bingjun Sun2,4( ), Jin Sun2,4( )
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
Department of Pharmacy, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China
Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education, Shenyang 110016, China

§ Yuanhao Yu, Shiyi Zuo, and Jiaxuan Song contributed equally to this work.

Show Author Information
The online version of the original article can be found at:
https://doi.org/10.1007/s12274-024-6533-5

Keywords

fatty acid prodrugalbumindoxorubicinpH-sensitive bondnanomedicines
Nano Research
Volume 17 Issue 7,
July 2024
Pages 6774-6775
DOI: 10.1007/s12274-024-6611-8
Cite this article:
Yu Y, Zuo S, Song J, et al. Erratum to: Balancing efficacy and safety of doxorubicin-loaded albumin nanoparticles utilizing pH-sensitive doxorubicin-fatty acid prodrugs. Nano Research, 2024, 17(7): 6774-6775. https://doi.org/10.1007/s12274-024-6611-8

236

Views

10

Downloads

1

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Published: 20 March 2024
© Tsinghua University Press 2024
Return